CDK20/CycH Recombinant Human Active Protein Kinase
CDK20 is a major controller of cell cycle checkpoints, which regulate cell growth and proliferation and perform a role in the development of many malignancies. CDK20 is thought to have Cyclin-dependent activating kinase (CAK) activity for CDK2 when it is complexed with Cyclin H. CDK20/CycH Recombinant Human Active Protein Kinase can be used to study the function of CDK20/CycH[1].
Product Specifications
UNSPSC
12352211
Target
CDK
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Smiles
[CDK20/CycHRecombinantHumanActiveProteinKinase]
References & Citations
[1]Chivukula S, et al. The Role of CDK20 Protein in Carcinogenesis. Curr Drug Targets. 2023;24 (10) :790-796.
Shipping Conditions
Room temperature
Scientific Category
Enzyme
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC683249-500 1x 500 µL
CD1a / HTA1 (Mature Langerhans Cells Marker) (C1A/3249), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680172-500 1x 500 µL
CD45 / LCA (135-4C5), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LY428736 100 µg
UBE2QL1 (NM_001145161) Human Over-expression Lysate
Sign In for Pricing
View Details 